AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation (MS) delivered simultaneously to and 20 msec after S1
Number of subjects: 8
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation (MS) delivered 200 msec after S1
Number of subjects: 8
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp stimulation of restricted scalp positions contralateral to the finger stimulated
Number of subjects: 8
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensities of finger stimulation and high intensities of MS
Number of subjects: 8
Study 1718723 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of motor evoked responses in a peripheral hand muscle
Number of subjects: 8
Study 29453751 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole ewe's milk yogurt (EW, 5.8% fat)
Number of subjects: 30
Study 28935227 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face 30-minute physiotherapy education and training session on pulmonary complications, early ambulation, and breathing exercises
Number of subjects: 29
Study 28935227 — intervention group
Group type: COMPARATOR
Intervention: Information booklet about preventing pulmonary complications with early ambulation and breathing exercises
Number of subjects: 29
Study 26586096 — intervention group
Group type: EXPERIMENTAL
Intervention: F1.8 formula (1.8 g protein/418.4 kJ)
Number of subjects: 238
Study 26586096 — intervention group
Group type: EXPERIMENTAL
Intervention: F2.7 formula (2.7 g protein/418.4 kJ)
Number of subjects: 238
Study 26586096 — intervention group
Group type: EXPERIMENTAL
Intervention: F1.8 formula
Number of subjects: 238
Study 26586096 — intervention group
Group type: EXPERIMENTAL
Intervention: F2.7 formula
Number of subjects: 238
Study 26586096 — intervention group
Group type: EXPERIMENTAL
Intervention: F1.8 and F2.7 formula
Number of subjects: 238
Study 26586096 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed group (reference)
Number of subjects: 238
Study 24613908 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for at least 5 months
Number of subjects: 311
Study 24613908 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Benefit Response (CBR)
Number of subjects: 311
Study 24613908 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of CBR (n = 62)
Number of subjects: 311
Study 24613908 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically meaningful improvements in PROs (n = 100-116)
Number of subjects: 311
Study 22513706 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent high-volume predilution on-line haemofiltration (HF)
Number of subjects: 273
Study 22513706 — intervention group
Group type: COMPARATOR
Intervention: Standard intermittent haemodialysis (HD)
Number of subjects: 273
Study 20565206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued reaction time task with dual-response version (Experiment 1)
Number of subjects: 0
Study 20565206 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential conditioning procedure (Experiments 2 and 3)
Number of subjects: 0
Study 20565206 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued reaction time task (Experiment 3)
Number of subjects: 0
Study 17660174 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 80
Study 17660174 — intervention group
Group type: COMPARATOR
Intervention: Conventional knot tying and electrocautery
Number of subjects: 80
Study 16186005 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported expressed anger (very low and very high)
Number of subjects: 2
Study 16186005 — intervention group
Group type: COMPARATOR
Intervention: Self-reported expressed anger
Number of subjects: 2
Study 12030948 — intervention group
Group type: EXPERIMENTAL
Intervention: Red pepper powder (2.5 g/day for 5 weeks)
Number of subjects: 30
Study 12030948 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 9914576 — intervention group
Group type: EXPERIMENTAL
Intervention: Crinone 4%
Number of subjects: 127
Study 9914576 — intervention group
Group type: EXPERIMENTAL
Intervention: Crinone 8%
Number of subjects: 127
Study 7485681 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin‐ and lambdacyhalothrin‐impregnated bed nets
Number of subjects: 35000
Study 7485681 — intervention group
Group type: COMPARATOR
Intervention: Control communities (no bed nets)
Number of subjects: 35000
Study 2258591 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopamiron 370
Number of subjects: 50
Study 2258591 — intervention group
Group type: COMPARATOR
Intervention: Telebrix Hystero
Number of subjects: 50
Study 7294869 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal blanket
Number of subjects: 44
Study 7294869 — intervention group
Group type: COMPARATOR
Intervention: Topical paraffin
Number of subjects: 44
Study 31586540 — intervention group
Group type: EXPERIMENTAL
Intervention: VeCS technique
Number of subjects: 40
Study 31586540 — intervention group
Group type: COMPARATOR
Intervention: Cystoscopy
Number of subjects: 40
Study 27306883 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Management Training-Oregon Model (PMTO)
Number of subjects: 146
Study 27306883 — intervention group
Group type: COMPARATOR
Intervention: Care As Usual (CAU)
Number of subjects: 146
Study 26091023 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% Hypertonic Saline (250 mL)
Number of subjects: 294
Study 26091023 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% Hypertonic Saline (250 mL)
Number of subjects: 294
Study 26091023 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's Solution (LRS) (250 mL)
Number of subjects: 294
Study 24597922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST)
Number of subjects: 56
Study 24597922 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study 22217183 — intervention group
Group type: EXPERIMENTAL
Intervention: Bothersome tinnitus patients
Number of subjects: 17
Study 22217183 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 17
Study 18987287 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (90-min free weight lifting session followed by a 6.5-h rest)
Number of subjects: 11
Study 18987287 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (60-min run followed by a 7-h rest)
Number of subjects: 11
Study 18987287 — intervention group
Group type: COMPARATOR
Intervention: Control (8-h rest)
Number of subjects: 11
Study 15978753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen 0.625 mg/day (CEE 0.625 mg)
Number of subjects: 88
Study 15978753 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal estradiol 50 microg/day (tE2)
Number of subjects: 88
Study 15978753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogen 0.625 mg/day plus medroxyprogesterone acetate 2.5 mg/day (CEE 0.625 mg/MPA 2.5 mg)
Number of subjects: 88
Study 15978753 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 2 mg 17‐beta estradiol combined with 1 mg norethistrone acetate (E2/norethistrone)
Number of subjects: 88
Study 15978753 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 88
Study 12975428 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTGA patients (group A)
Number of subjects: 15
Study 12975428 — intervention group
Group type: EXPERIMENTAL
Intervention: CCTGA patients (group B)
Number of subjects: 15
Study 12975428 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet bonding with OptiBond Solo
Number of subjects: 60
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet bonding with PermaQuick PQI
Number of subjects: 60
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet bonding with Prime & Bond NT (one coat)
Number of subjects: 60
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet bonding with Prime & Bond NT (two coats)
Number of subjects: 60
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet bonding with Prime & Bond 2.1
Number of subjects: 60
Study 11764834 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry bonding with all materials
Number of subjects: 60
Study 11764834 — intervention group
Group type: COMPARATOR
Intervention: Wet bonding vs Dry bonding for each material
Number of subjects: 60
Study 8665771 — intervention group
Group type: EXPERIMENTAL
Intervention: Active standing
Number of subjects: 25
Study 8665771 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase between IRP and blood pressure at 0.1 Hz
Number of subjects: 25
Study 8665771 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase between IRP and blood pressure at 0.25 Hz
Number of subjects: 25
Study 8665771 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial and IRP fluctuations
Number of subjects: 25
Study 1893805 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral zinc supplementation (zinc sulfate 600 mg/day)
Number of subjects: 15
Study 1893805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6620373 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-nicotine cigarette
Number of subjects: 0
Study 6620373 — intervention group
Group type: EXPERIMENTAL
Intervention: High-nicotine cigarette
Number of subjects: 0
Study 6620373 — intervention group
Group type: COMPARATOR
Intervention: No smoking
Number of subjects: 0
Study 30604577 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure therapy
Number of subjects: 177
Study 30604577 — intervention group
Group type: COMPARATOR
Intervention: Previous stroke
Number of subjects: 177
Study 30604577 — intervention group
Group type: COMPARATOR
Intervention: Adequate adherence at 1 month
Number of subjects: 177
Study 29140378 — intervention group
Group type: COMPARATOR
Intervention: Implant-supported fixed prosthesis (group 1)
Number of subjects: 20
Study 29140378 — intervention group
Group type: COMPARATOR
Intervention: Implant-supported fixed prosthesis (group 2)
Number of subjects: 20
Study 25121397 — intervention group
Group type: EXPERIMENTAL
Intervention: ProSeal Laryngeal Mask Airway (LMA)
Number of subjects: 42
Study 25121397 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 42
Study 23245807 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (20 mgqd)
Number of subjects: 12
Study 23245807 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (16 mgqd)
Number of subjects: 12
Study 23245807 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 12
Study 23245807 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium intake and blood pressure
Number of subjects: 12
Study 23245807 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemia and HbA1c
Number of subjects: 12
Study 21281262 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locked plating (n = 33)
Number of subjects: 63
Study 21281262 — intervention group
Group type: COMPARATOR
Intervention: Bridging external fixation
Number of subjects: 63
Study 18156641 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of elemental iron/daily added to school meals (group A)
Number of subjects: 728
Study 18156641 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of elemental iron/daily added to school meals (group B)
Number of subjects: 728
Study 17062141 — intervention group
Group type: EXPERIMENTAL
Intervention: Work style and physical activity intervention
Number of subjects: 0
Study 17062141 — intervention group
Group type: EXPERIMENTAL
Intervention: Work style intervention
Number of subjects: 0
Study 17062141 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 14745877 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI of 5‐FU
Number of subjects: 316
Study 14745877 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 316
Study 11682399 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg IM
Number of subjects: 30
Study 11682399 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 30
Study 9041597 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria‐tetanus toxoids with pertussis toxoid
Number of subjects: 3450
Study 9041597 — intervention group
Group type: COMPARATOR
Intervention: Diphtheria‐tetanus toxoids without pertussis toxoid (Control)
Number of subjects: 3450
Study 7929824 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion at 21.5 pmol/kg per min for 2.5 h during hyperinsulinemic-euglycemic clamp
Number of subjects: 17
Study 7929824 — intervention group
Group type: COMPARATOR
Intervention: Control saline infusion (0.45% saline)
Number of subjects: 17
Study 3345042 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen challenge
Number of subjects: 7
Study 3345042 — intervention group
Group type: COMPARATOR
Intervention: Saline insufflation
Number of subjects: 7
Study 3345042 — intervention group
Group type: COMPARATOR
Intervention: Distilled water insufflation
Number of subjects: 7
Study 29453433 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier Oral Feeding Group (initiated at 30 weeks' PMA)
Number of subjects: 66
Study 29453433 — intervention group
Group type: COMPARATOR
Intervention: Later Oral Feeding Group (initiated at 33 weeks' PMA)
Number of subjects: 66
Study 27317358 — intervention group
Group type: EXPERIMENTAL
Intervention: Featback (psychoeducation and fully automated self-monitoring and feedback system)
Number of subjects: 354
Study 27317358 — intervention group
Group type: EXPERIMENTAL
Intervention: Featback supplemented with low-intensity (weekly) digital therapist support
Number of subjects: 354
Study 27317358 — intervention group
Group type: EXPERIMENTAL
Intervention: Featback supplemented with high-intensity (3 times a week) digital therapist support
Number of subjects: 354
Study 27317358 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 354
Study 24289887 — intervention group
Group type: EXPERIMENTAL
Intervention: rhEPO (40,000 IU intravenously, twice a week for 5 weeks)
Number of subjects: 26
Study 24289887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24341348 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 days of inpatient rehabilitation followed by a 6-week hybrid home program
Number of subjects: 140
Study 24341348 — intervention group
Group type: COMPARATOR
Intervention: Usual care (a 6-week hybrid home program)
Number of subjects: 140
Study 20206217 — intervention group
Group type: EXPERIMENTAL
Intervention: Dried plums
Number of subjects: 19
Study 20206217 — intervention group
Group type: COMPARATOR
Intervention: Low-fat cookies
Number of subjects: 19
Study 18427724 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day
Number of subjects: 33
Study 18427724 — intervention group
Group type: COMPARATOR
Intervention: Alfacalcidol 1.0 mug/day
Number of subjects: 33
Study 16614713 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine therapy with activities from 1000 to 6000 MBq
Number of subjects: 68
Study 16614713 — intervention group
Group type: EXPERIMENTAL
Intervention: First course of radioiodine therapy
Number of subjects: 68
Study 15143855 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with known exposure to molds
Number of subjects: 1500
Study 15143855 — intervention group
Group type: EXPERIMENTAL
Intervention: Mold-exposed patients
Number of subjects: 1500
Study 15143855 — intervention group
Group type: COMPARATOR
Intervention: Healthy blood donor controls
Number of subjects: 1500
Study 10856472 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile IV GnRH (10-20 microgram/90 min) after GnRH‐agonist down‐regulation
Number of subjects: 28
Study 10856472 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) (50-150 mg; cycle days 3-7)
Number of subjects: 28
Study 9173664 — intervention group
Group type: EXPERIMENTAL
Intervention: Mannitol and low sodium solution
Number of subjects: 32
Study 9173664 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol and high sodium concentration solution
Number of subjects: 32
Study 9173664 — intervention group
Group type: COMPARATOR
Intervention: Polyethylene glycol and low sodium solution
Number of subjects: 32
Study 9173664 — intervention group
Group type: EXPERIMENTAL
Intervention: All three solutions
Number of subjects: 32
Study 7516648 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (2 million KIU intravenously before cardiopulmonary bypass and 2 million KIU in the filling liquid of the bypass circuit)
Number of subjects: 60
Study 7516648 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60
Study 7516648 — intervention group
Group type: COMPARATOR
Intervention: Control (no aprotinin)
Number of subjects: 60
Study 3031260 — intervention group
Group type: EXPERIMENTAL
Intervention: High phosphorus intake (1.67 mmol/kg/d, 50 mg/kg/d)
Number of subjects: 27
Study 3031260 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate phosphorus intake (1.34 mmol/kg/d, 40 mg/kg/d)
Number of subjects: 27
Study 3031260 — intervention group
Group type: EXPERIMENTAL
Intervention: Low phosphorus intake (1.01 mmol/kg/d, 30 mg/kg/d)
Number of subjects: 27
Study 31529450 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone (BMZ)
Number of subjects: 2831
Study 31529450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2831
Study 29108405 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 1200 mg
Number of subjects: 113
Study 29108405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 26598750 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person counseling (n = 33)
Number of subjects: 100
Study 26598750 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling (n = 34)
Number of subjects: 100
Study 26598750 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) (n = 33)
Number of subjects: 100
Study 26598750 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined weight loss intervention groups (in-person and telephone)
Number of subjects: 100
Study 26598750 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 100
Study 24739318 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg prednisone daily for 5 days
Number of subjects: 79
Study 24739318 — intervention group
Group type: COMPARATOR
Intervention: Identical‐appearing placebo
Number of subjects: 79
Study 22983930 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intervention (gait analysis and strength data collection)
Number of subjects: 38
Study 22983930 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased preoperative quadriceps strength
Number of subjects: 38
Study 22983930 — intervention group
Group type: COMPARATOR
Intervention: No increase in preoperative quadriceps strength
Number of subjects: 38
Study 19729663 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 5993
Study 19729663 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5993
Study 17313691 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal Doppler-guided fluid management
Number of subjects: 162
Study 17313691 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard hemodynamic management)
Number of subjects: 162
Study 14963484 — intervention group
Group type: EXPERIMENTAL
Intervention: anterior Greenbaum sub‐Tenon cannula
Number of subjects: 150
Study 14963484 — intervention group
Group type: EXPERIMENTAL
Intervention: mid Kumar‐Dodds sub‐Tenon cannula
Number of subjects: 150
Study 14963484 — intervention group
Group type: EXPERIMENTAL
Intervention: posterior Steven's sub‐Tenon cannula
Number of subjects: 150
Study 11728657 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 84
Study 11728657 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 84
Study 9539190 — intervention group
Group type: EXPERIMENTAL
Intervention: Indole‐3-carbinol (13C), 400 mg for two months
Number of subjects: 5
Study 7961534 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy (exposure in vivo and response prevention)
Number of subjects: 0
Study 7961534 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic behavior therapy
Number of subjects: 0
Study 7961534 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework exposure and response prevention
Number of subjects: 0
Study 2628523 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive motion palpation protocol
Number of subjects: 60
Study 1173830 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up care intervention group (assigned by a follow-up clerk)
Number of subjects: 144
Study 1173830 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard follow-up)
Number of subjects: 144
Study 1173830 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up care intervention group
Number of subjects: 144
Study 1173830 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study 31821098 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin (0.2 mg/kg 3 times daily)
Number of subjects: 49
Study 31821098 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 49
Study 31165710 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment group (ITG) - Big White Wall (BWW) intervention for 3 months
Number of subjects: 812
Study 31165710 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment group (DTG) - no intervention for 3 months
Number of subjects: 812
Study 31165710 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BWW user groups
Number of subjects: 812
Study 28825957 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranilast 8% liposomal gel
Number of subjects: 26
Study 28825957 — intervention group
Group type: COMPARATOR
Intervention: Placebo (tranilast‐free liposomal gel)
Number of subjects: 26
Study 26093951 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chronotherapy (administered at 18:00)
Number of subjects: 41
Study 26093951 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-based chronotherapy
Number of subjects: 41
Study 26093951 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin administered at 18:00
Number of subjects: 41